Skip to main content
Erschienen in: Heart and Vessels 12/2016

16.06.2016 | Short Communication

Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice

verfasst von: Yoshiro Naito, Manami Hosokawa, Hisashi Sawada, Makiko Oboshi, Toshihiro Iwasaku, Yoshitaka Okuhara, Akiyo Eguchi, Koichi Nishimura, Yuko Soyama, Shinichi Hirotani, Toshiaki Mano, Masaharu Ishihara, Tohru Masuyama

Erschienen in: Heart and Vessels | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Several recent observations provide the association of iron deficiency with pulmonary hypertension (PH) in human and animal studies. However, it remains completely unknown whether PH leads to iron deficiency or iron deficiency enhances the development of PH. In addition, it is obscure whether iron is associated with the development of pulmonary vascular remodeling in PH. In this study, we investigate the impacts of dietary iron restriction on the development of hypoxia-induced pulmonary vascular remodeling in mice. Eight- to ten-week-old male C57BL/6J mice were exposed to chronic hypoxia for 4 weeks. Mice exposed to hypoxia were randomly divided into two groups and were given a normal diet or an iron-restricted diet. Mice maintained in room air served as normoxic controls. Chronic hypoxia induced pulmonary vascular remodeling, while iron restriction led a modest attenuation of this change. In addition, chronic hypoxia exhibited increased RV systolic pressure, which was attenuated by iron restriction. Moreover, the increase in RV cardiomyocyte cross-sectional area and RV interstitial fibrosis was observed in mice exposed to chronic hypoxia. In contrast, iron restriction suppressed these changes. Consistent with these changes, RV weight to left ventricular + interventricular septum weight ratio was increased in mice exposed to chronic hypoxia, while this increment was inhibited by iron restriction. Taken together, these results suggest that iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice.
Literatur
1.
Zurück zum Zitat Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB, National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure (2006) Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation 114:1883–1891CrossRefPubMed Voelkel NF, Quaife RA, Leinwand LA, Barst RJ, McGoon MD, Meldrum DR, Dupuis J, Long CS, Rubin LJ, Smart FW, Suzuki YJ, Gladwin M, Denholm EM, Gail DB, National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure (2006) Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Circulation 114:1883–1891CrossRefPubMed
2.
Zurück zum Zitat Hatano M, Yamada H, Fukuda K, Yoshioka K, Funauchi M, Kuwana M, Sata M, Taniguchi M, Nakanishi N, Saito T, Saji T, Sasayama S (2015) Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension. Heart Vessels 30:798–804CrossRefPubMed Hatano M, Yamada H, Fukuda K, Yoshioka K, Funauchi M, Kuwana M, Sata M, Taniguchi M, Nakanishi N, Saito T, Saji T, Sasayama S (2015) Effects of the endothelin receptor antagonist bosentan on hemodynamics and exercise capacity in Japanese patients with mildly symptomatic pulmonary arterial hypertension. Heart Vessels 30:798–804CrossRefPubMed
3.
Zurück zum Zitat Guo Y, Su L, Li Y, Guo N, Xie L, Zhang D, Zhang X, Li H, Zhang G, Wang Y, Liu C (2014) The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats. Heart Vessels 29:520–531CrossRefPubMed Guo Y, Su L, Li Y, Guo N, Xie L, Zhang D, Zhang X, Li H, Zhang G, Wang Y, Liu C (2014) The synergistic therapeutic effect of hepatocyte growth factor and granulocyte colony-stimulating factor on pulmonary hypertension in rats. Heart Vessels 29:520–531CrossRefPubMed
4.
Zurück zum Zitat Kaluza J, Larsson SC, Håkansson N, Wolk A (2014) Heme iron intake and acute myocardial infarction: a prospective study of men. Int J Cardiol 172:155–160CrossRefPubMed Kaluza J, Larsson SC, Håkansson N, Wolk A (2014) Heme iron intake and acute myocardial infarction: a prospective study of men. Int J Cardiol 172:155–160CrossRefPubMed
5.
Zurück zum Zitat Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JS, Wharton J, Wilkins MR (2011) Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol 58:300–309CrossRefPubMed Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JS, Wharton J, Wilkins MR (2011) Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol 58:300–309CrossRefPubMed
6.
Zurück zum Zitat Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A (2011) Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 37:1386–1391CrossRefPubMed Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A (2011) Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 37:1386–1391CrossRefPubMed
7.
Zurück zum Zitat Eguchi A, Naito Y, Iwasaku T, Okuhara Y, Morisawa D, Sawada H, Nishimura K, Oboshi M, Fujii K, Mano T, Masuyama T, Hirotani S (2016) Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice. Heart Vessels 31:222–229CrossRefPubMed Eguchi A, Naito Y, Iwasaku T, Okuhara Y, Morisawa D, Sawada H, Nishimura K, Oboshi M, Fujii K, Mano T, Masuyama T, Hirotani S (2016) Association of dietary iron restriction with left ventricular remodeling after myocardial infarction in mice. Heart Vessels 31:222–229CrossRefPubMed
8.
Zurück zum Zitat Naito Y, Hosokawa M, Hao H, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Hirota S, Ohyanagi M, Tsujino T, Masuyama T (2013) Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats. Biochem Biophys Res Commun 436:145–151CrossRefPubMed Naito Y, Hosokawa M, Hao H, Sawada H, Hirotani S, Iwasaku T, Okuhara Y, Eguchi A, Hirota S, Ohyanagi M, Tsujino T, Masuyama T (2013) Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats. Biochem Biophys Res Commun 436:145–151CrossRefPubMed
9.
Zurück zum Zitat Robinson JC, Graham BB, Rouault TC, Tuder RM (2014) The crossroads of iron with hypoxia and cellular metabolism implications in the pathobiology of pulmonary hypertension. Am J Respir Cell Mol Biol 51:721–729CrossRefPubMedPubMedCentral Robinson JC, Graham BB, Rouault TC, Tuder RM (2014) The crossroads of iron with hypoxia and cellular metabolism implications in the pathobiology of pulmonary hypertension. Am J Respir Cell Mol Biol 51:721–729CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Ghio AJ (2009) Disruption of iron homeostasis and lung disease. Biochim Biophys Acta 1790:731–739CrossRefPubMed Ghio AJ (2009) Disruption of iron homeostasis and lung disease. Biochim Biophys Acta 1790:731–739CrossRefPubMed
11.
Zurück zum Zitat Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L (2015) Iron homeostasis and pulmonary hypertension: Iron deficiency leads to pulmonary vascular remodeling in the rat. Circ Res 116:1680–1690CrossRefPubMed Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L (2015) Iron homeostasis and pulmonary hypertension: Iron deficiency leads to pulmonary vascular remodeling in the rat. Circ Res 116:1680–1690CrossRefPubMed
12.
Zurück zum Zitat Naito Y, Hosokawa M, Sawada H, Oboshi M, Hirotani S, Iwasaku T, Okuhara Y, Morisawa D, Eguchi A, Nishimura K, Soyama Y, Fujii K, Mano T, Ishihara M, Tsujino T, Masuyama T (2015) Transferrin receptor 1 in chronic hypoxia-induced pulmonary vascular remodeling. Am J Hypertens. doi:10.1093/ajh/hpv163 PubMed Naito Y, Hosokawa M, Sawada H, Oboshi M, Hirotani S, Iwasaku T, Okuhara Y, Morisawa D, Eguchi A, Nishimura K, Soyama Y, Fujii K, Mano T, Ishihara M, Tsujino T, Masuyama T (2015) Transferrin receptor 1 in chronic hypoxia-induced pulmonary vascular remodeling. Am J Hypertens. doi:10.​1093/​ajh/​hpv163 PubMed
13.
Zurück zum Zitat Ruiter G, Manders E, Happé CM, Schalij I, Groepenhoff H, Howard LS, Wilkins MR, Bogaard HJ, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A (2015) Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm Circ 5:466–472CrossRefPubMedPubMedCentral Ruiter G, Manders E, Happé CM, Schalij I, Groepenhoff H, Howard LS, Wilkins MR, Bogaard HJ, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A (2015) Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm Circ 5:466–472CrossRefPubMedPubMedCentral
Metadaten
Titel
Iron is associated with the development of hypoxia-induced pulmonary vascular remodeling in mice
verfasst von
Yoshiro Naito
Manami Hosokawa
Hisashi Sawada
Makiko Oboshi
Toshihiro Iwasaku
Yoshitaka Okuhara
Akiyo Eguchi
Koichi Nishimura
Yuko Soyama
Shinichi Hirotani
Toshiaki Mano
Masaharu Ishihara
Tohru Masuyama
Publikationsdatum
16.06.2016
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 12/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-016-0860-8

Weitere Artikel der Ausgabe 12/2016

Heart and Vessels 12/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.